메뉴 건너뛰기




Volumn 35, Issue 7-8, 2006, Pages 1138-1142

Treatment of chronic lupus erythematosus with sulfasalazine in 18 patients: Reappraisal;Traitement du lupus érythémateux chronique par sulfasalazine (18 cas)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; ANTINUCLEAR ANTIBODY; LIVER ENZYME; SALAZOSULFAPYRIDINE;

EID: 33745846480     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0755-4982(06)74770-4     Document Type: Article
Times cited : (3)

References (36)
  • 1
    • 25444437498 scopus 로고    scopus 로고
    • 0,1% tacrolimus ointment in the treatment of discoid lupus erythematosus
    • Heffernan M, Nelson M, Smith D, Chung J. 0,1% tacrolimus ointment in the treatment of discoid lupus erythematosus. Arch Dermatol. 2005; 141: 1170-1.
    • (2005) Arch Dermatol , vol.141 , pp. 1170-1171
    • Heffernan, M.1    Nelson, M.2    Smith, D.3    Chung, J.4
  • 3
    • 0036434289 scopus 로고    scopus 로고
    • Successful treatment of chronic discoid lupus erythematosus of the scalp with imiquimod
    • Gerdsen R, Wenzel J, Uerlich M, Bieber T, Petrow W. Successful treatment of chronic discoid lupus erythematosus of the scalp with imiquimod. Dermatology. 2002; 205: 416-8.
    • (2002) Dermatology , vol.205 , pp. 416-418
    • Gerdsen, R.1    Wenzel, J.2    Uerlich, M.3    Bieber, T.4    Petrow, W.5
  • 4
    • 8344253557 scopus 로고    scopus 로고
    • Update on the management of cutaneous lupus erythematosus
    • Callen JP. Update on the management of cutaneous lupus erythematosus. Br J Dermatol. 2004; 151: 731-6.
    • (2004) Br J Dermatol , vol.151 , pp. 731-736
    • Callen, J.P.1
  • 5
    • 22944467522 scopus 로고    scopus 로고
    • Efficacy and safety of methotrexate in recalcitrant cutaneous lupus erythematosus: Results of a retrospective study in 43 patients
    • Wenzel J, Brähler S, Bauer R, Bieber T, Tüting T. Efficacy and safety of methotrexate in recalcitrant cutaneous lupus erythematosus: results of a retrospective study in 43 patients. Br J Dermatol. 2005; 153: 157-62.
    • (2005) Br J Dermatol , vol.153 , pp. 157-162
    • Wenzel, J.1    Brähler, S.2    Bauer, R.3    Bieber, T.4    Tüting, T.5
  • 6
    • 0034941002 scopus 로고    scopus 로고
    • Treatment of resistant discoid lupus erythematosus of the palms and soles with mycophenolate mofetil
    • Goyal S, Nousari HC. Treatment of resistant discoid lupus erythematosus of the palms and soles with mycophenolate mofetil. J Am Acad Dermatol. 2001; 45: 142-4.
    • (2001) J Am Acad Dermatol , vol.45 , pp. 142-144
    • Goyal, S.1    Nousari, H.C.2
  • 9
    • 0030898186 scopus 로고    scopus 로고
    • NAT2 genotyping and efficacy of sulfasalazine in patients with chronic discoid lupus erythematosus
    • Sabbagh N, Delaporte E, Marez D, Lo-Guidice JM, Piette F, Broly F. NAT2 genotyping and efficacy of sulfasalazine in patients with chronic discoid lupus erythematosus. Pharmacogenetics. 1997; 7: 131-5.
    • (1997) Pharmacogenetics , vol.7 , pp. 131-135
    • Sabbagh, N.1    Delaporte, E.2    Marez, D.3    Lo-Guidice, J.M.4    Piette, F.5    Broly, F.6
  • 11
    • 14544308953 scopus 로고    scopus 로고
    • Successful treatment of lichen planus with sulfasalazine in 20 patients
    • Bauza A, Espana A, Gil P, Lloret P, Vazquez Doval FJ. Successful treatment of lichen planus with sulfasalazine in 20 patients. Int J Dermatol 2005; 44: 158-62.
    • (2005) Int J Dermatol , vol.44 , pp. 158-162
    • Bauza, A.1    Espana, A.2    Gil, P.3    Lloret, P.4    Vazquez Doval, F.J.5
  • 12
    • 84996119291 scopus 로고
    • Discoid erythematosus responsive to sulphasalazine
    • Carmichael AJ, Paul CJ. Discoid erythematosus responsive to sulphasalazine. Br J Dermatol. 1991; 125: 291.
    • (1991) Br J Dermatol , vol.125 , pp. 291
    • Carmichael, A.J.1    Paul, C.J.2
  • 13
    • 0029913960 scopus 로고    scopus 로고
    • Efficacy of sulfasalazine in discoid lupus erythematosus
    • Artuz F, Lenk N, Deniz N, Alli N. Efficacy of sulfasalazine in discoid lupus erythematosus. Int J Dermatol. 1996; 35: 746-8.
    • (1996) Int J Dermatol , vol.35 , pp. 746-748
    • Artuz, F.1    Lenk, N.2    Deniz, N.3    Alli, N.4
  • 14
    • 84858913857 scopus 로고    scopus 로고
    • Traitement du lupus érythémateux cutané résistant par la sulfasalazine: Rapport bénéfice-risque à évaluer
    • Lagrange S, Piette JC, Becherel PA, Cacoub P, Chosidow O, Francès C. Traitement du lupus érythémateux cutané résistant par la sulfasalazine: rapport bénéfice-risque à évaluer. Ann Dermatol Venereol 1998; 125(Suppl 3): S42-S43.
    • (1998) Ann Dermatol Venereol , vol.125 , Issue.3 SUPPL.
    • Lagrange, S.1    Piette, J.C.2    Becherel, P.A.3    Cacoub, P.4    Chosidow, O.5    Francès, C.6
  • 15
    • 0036786888 scopus 로고    scopus 로고
    • Sulphasalazine and mesalazine: Serious adverse reactions reevaluated on the basis of suspected adverse reaction reports to the Committee on safety of medicines
    • Ransford RAJ, Langman MJS. Sulphasalazine and mesalazine : serious adverse reactions reevaluated on the basis of suspected adverse reaction reports to the Committee on safety of medicines. Gut. 2002; 51: 536-9.
    • (2002) Gut , vol.51 , pp. 536-539
    • Ransford, R.A.J.1    Langman, M.J.S.2
  • 16
    • 0028880443 scopus 로고
    • Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis
    • Roujeau JC, Kelly JP, Naldi L, Rzany B, Stern RS, Anderson T et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med. 1995; 333: 1600-7.
    • (1995) N Engl J Med , vol.333 , pp. 1600-1607
    • Roujeau, J.C.1    Kelly, J.P.2    Naldi, L.3    Rzany, B.4    Stern, R.S.5    Anderson, T.6
  • 17
    • 0022541810 scopus 로고
    • Sulphasalazine for rheumatoid arthritis: Toxicity in 774 patients monitored for one to 11 years
    • Amos RS, Pullar T, Bax DE, Situnayake D, Capell HA, McConkey B. Sulphasalazine for rheumatoid arthritis: toxicity in 774 patients monitored for one to 11 years. Br Med J. 1986; 293: 420-3.
    • (1986) Br Med J , vol.293 , pp. 420-423
    • Amos, R.S.1    Pullar, T.2    Bax, D.E.3    Situnayake, D.4    Capell, H.A.5    McConkey, B.6
  • 18
    • 0015916139 scopus 로고
    • Adverse reactions during salicylazosulfapyridine therapy and the relation with drug metabolism and acetylator phenotype
    • Das KM, Eastwood MA, McManus JPA, Sircus W. Adverse reactions during salicylazosulfapyridine therapy and the relation with drug metabolism and acetylator phenotype. N Engl J Med. 1973; 289: 491-5.
    • (1973) N Engl J Med , vol.289 , pp. 491-495
    • Das, K.M.1    Eastwood, M.A.2    McManus, J.P.A.3    Sircus, W.4
  • 19
    • 0022537791 scopus 로고
    • Side effects profile on 200 patients with inflammatory arthritides treated with sulphasalazine
    • Farr M, Scott DGI, Bacon PA. Side effects profile on 200 patients with inflammatory arthritides treated with sulphasalazine. Drugs. 1986; 32: 49-53.
    • (1986) Drugs , vol.32 , pp. 49-53
    • Farr, M.1    Scott, D.G.I.2    Bacon, P.A.3
  • 20
    • 0042423740 scopus 로고    scopus 로고
    • Photo-induced Stevens-Johnson syndrome due to sulfasalazine therapy
    • Borras-Blasco J, Navarro-Ruiz A, Matarredona J. Photo-induced Stevens-Johnson syndrome due to sulfasalazine therapy. Ann Pharmacother. 2003; 37: 1241-3.
    • (2003) Ann Pharmacother , vol.37 , pp. 1241-1243
    • Borras-Blasco, J.1    Navarro-Ruiz, A.2    Matarredona, J.3
  • 23
    • 0032616812 scopus 로고    scopus 로고
    • Acute pancreatitis induced by drugs derived from 5-aminosalicylic acid: Case report and review of the literature
    • Decocq G, Gras-Champel V, Vrolant-Mille C, Delcenserie R, Sauve L, Masson H et al. Acute pancreatitis induced by drugs derived from 5-aminosalicylic acid : case report and review of the literature. Therapie. 1999; 54: 41-8.
    • (1999) Therapie , vol.54 , pp. 41-48
    • Decocq, G.1    Gras-Champel, V.2    Vrolant-Mille, C.3    Delcenserie, R.4    Sauve, L.5    Masson, H.6
  • 24
    • 10844279275 scopus 로고    scopus 로고
    • N-acetyltransferase 2 genotype-related sulfapyridine acetylation and its adverse effects
    • Tanigawara Y, Kita T, Aoyama N, Gobara M, Komada F, Sakai T et al. N-acetyltransferase 2 genotype-related sulfapyridine acetylation and its adverse effects. Biol Pharm Bull. 2002; 25: 1058-62.
    • (2002) Biol Pharm Bull , vol.25 , pp. 1058-1062
    • Tanigawara, Y.1    Kita, T.2    Aoyama, N.3    Gobara, M.4    Komada, F.5    Sakai, T.6
  • 25
    • 1242314682 scopus 로고    scopus 로고
    • N-acetyltransferase 2 genotype-related efficacy of sulphasalazine in patients with rheumatoid arthritis
    • Kumagai S, Komada F, Kita T, Morinobu A, Ozaki S, Ishida H et al. N-acetyltransferase 2 genotype-related efficacy of sulphasalazine in patients with rheumatoid arthritis. Pharmaceutic Res. 2004; 21: 324-9.
    • (2004) Pharmaceutic Res , vol.21 , pp. 324-329
    • Kumagai, S.1    Komada, F.2    Kita, T.3    Morinobu, A.4    Ozaki, S.5    Ishida, H.6
  • 26
    • 0034091884 scopus 로고    scopus 로고
    • Polymorphisms of NAT2 in relation to sulphasalazine-induced agranulocytosis
    • Wadelius M, Stjernberg E, Wiholm BE, Rane A. Polymorphisms of NAT2 in relation to sulphasalazine-induced agranulocytosis. Pharmacogenetics. 2000; 10: 35-41.
    • (2000) Pharmacogenetics , vol.10 , pp. 35-41
    • Wadelius, M.1    Stjernberg, E.2    Wiholm, B.E.3    Rane, A.4
  • 27
    • 0037863063 scopus 로고    scopus 로고
    • Slow acetylator genotypes as a possible risk factor for infectious mononucleosis-like syndrome induced by salazosulfapyridine
    • Ohtani T, Hiroi A, Sakurane M, Furukawa F. Slow acetylator genotypes as a possible risk factor for infectious mononucleosis-like syndrome induced by salazosulfapyridine. Br J Dermatol. 2003; 148: 1035-9.
    • (2003) Br J Dermatol , vol.148 , pp. 1035-1039
    • Ohtani, T.1    Hiroi, A.2    Sakurane, M.3    Furukawa, F.4
  • 29
    • 0036896055 scopus 로고    scopus 로고
    • Adverse effects of sulphasalazine in patients with rheumatoid arthritis are associated with diplotype configuration at the N-acetyltransferase 2 gene
    • Tanaka E, Taniguchi A, Urano W, Nakajima H, Matsuda Y, Kitamura Y et al. Adverse effects of sulphasalazine in patients with rheumatoid arthritis are associated with diplotype configuration at the N-acetyltransferase 2 gene. J Rheumatol 2002; 29: 2492-9.
    • (2002) J Rheumatol , vol.29 , pp. 2492-2499
    • Tanaka, E.1    Taniguchi, A.2    Urano, W.3    Nakajima, H.4    Matsuda, Y.5    Kitamura, Y.6
  • 30
    • 0028781678 scopus 로고
    • Sulfasalazine ou interféron dans le traitement du lupus: La poule, l'œuf, le loup
    • Piette JC, Francès C, Papo T, Godeau P. Sulfasalazine ou interféron dans le traitement du lupus : la poule, l'œuf, le loup. Presse Med. 1994; 23: 956.
    • (1994) Presse Med , vol.23 , pp. 956
    • Piette, J.C.1    Francès, C.2    Papo, T.3    Godeau, P.4
  • 32
    • 0029003640 scopus 로고
    • Sulphasalazine-induced autoimmune abnormalities in patients with rheumatic disease
    • Laversuch CJ, Collins DA, Charles PJ, Bourke BE. sulphasalazine-induced autoimmune abnormalities in patients with rheumatic disease. Br J Rheumatol. 1995; 34: 435-9.
    • (1995) Br J Rheumatol , vol.34 , pp. 435-439
    • Laversuch, C.J.1    Collins, D.A.2    Charles, P.J.3    Bourke, B.E.4
  • 33
    • 0032952111 scopus 로고    scopus 로고
    • Does sulphasalazine cause drug induced systemic lupus erythematosus? No effect evident in a prospective randomised trial of 200 rheumatoid patients treated with sulphasalazine or auranofin over five years
    • Gordon MM, Porter DR, Capell HA. Does sulphasalazine cause drug induced systemic lupus erythematosus? No effect evident in a prospective randomised trial of 200 rheumatoid patients treated with sulphasalazine or auranofin over five years. Ann Rheum Dis. 1999; 58: 288-90.
    • (1999) Ann Rheum Dis , vol.58 , pp. 288-290
    • Gordon, M.M.1    Porter, D.R.2    Capell, H.A.3
  • 34
    • 0027427575 scopus 로고
    • Follow-up of patients with double stranded DANN antibodies induced by sulphasalazine during the treatment of inflammatory rheumatic diseases
    • Mielke H, Wildhagen K, Mau W, Zeidler H. Follow-up of patients with double stranded DANN antibodies induced by sulphasalazine during the treatment of inflammatory rheumatic diseases. Scand J Rheumatol. 1993; 22: 299-301.
    • (1993) Scand J Rheumatol , vol.22 , pp. 299-301
    • Mielke, H.1    Wildhagen, K.2    Mau, W.3    Zeidler, H.4
  • 35
    • 85066729356 scopus 로고
    • Changes in antinuclear serology in patients with spondylarthropathy under sulphasalazine treatment
    • De Keyser F, Mielants H, Praet J, Goemaere S, Veys EM. Changes in antinuclear serology in patients with spondylarthropathy under sulphasalazine treatment. Br J Rheumatol. 1993; 32: 251-6.
    • (1993) Br J Rheumatol , vol.32 , pp. 251-256
    • De Keyser, F.1    Mielants, H.2    Praet, J.3    Goemaere, S.4    Veys, E.M.5
  • 36
    • 0025372354 scopus 로고
    • A one-year, open, prospective study of sulphasalazine in the treatment of rheumatoid arthritis: Adverse reactions and clinical response in relation to laboratory variables, drug and metabolite serum levels, and acetylator status
    • Chalmers IM, Sitar DS, Hunter T. A one-year, open, prospective study of sulphasalazine in the treatment of rheumatoid arthritis: adverse reactions and clinical response in relation to laboratory variables, drug and metabolite serum levels, and acetylator status. J Rheumatol. 1990; 17: 764-70.
    • (1990) J Rheumatol , vol.17 , pp. 764-770
    • Chalmers, I.M.1    Sitar, D.S.2    Hunter, T.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.